Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Effects of Antihypertensive Therapy During Pregnancy on Postpartum Blood Pressure Control.

Effects of Antihypertensive Therapy During Pregnancy on Postpartum Blood Pressure Control. Obstetrics and gynecology Martin, S. L., Kuo, H. C., Boggess, K., Dugoff, L., Sibai, B., Lawrence, K., Hughes, B. L., Bell, J., Aagaard, K., Gibson, K. S., Haas, D. M., Plante, L., Metz, T. D., Casey, B. M., Esplin, S., Longo, S., Hoffman, M., Saade, G. R., Foroutan, J., Tuuli, M. G., Owens, M. Y., Simhan, H. N., Frey, H. A., Rosen, T., Palatnik, A., Baker, S., August, P., Reddy, U. M., Kinzler, W., Su, E. J., Krishna, I., Nguyen, N., Norton, M. E., Skupski, D., El-Sayed, Y. Y., Ogunyemi, D., Galis, Z. S., Ambalavanan, N., Oparil, S., Librizzi, R., Pereira, L., Magann, E. F., Habli, M., Williams, S., Mari, G., Pridjian, G., McKenna, D. S., Parrish, M., Chang, E., Osmundson, S., Quinones, J., Werner, E., Szychowski, J. M., Tita, A. T. 2024

Abstract

To compare differences in postpartum blood pressure (BP) control (BP below 140/90 mm Hg) for participants with hypertension randomized to receive antihypertensive treatment compared with no treatment during pregnancy.This study was a planned secondary analysis of a multicenter, open-label, randomized controlled trial (The CHAP [Chronic Hypertension and Pregnancy] trial). Pregnant participants with mild chronic hypertension (BP below 160/105 mm Hg) were randomized into two groups: active (antihypertensive treatment) or control (no treatment unless severe hypertension, BP 160/105 mm Hg or higher). Study outcomes were BP control below 140/90 mm Hg (primary) and medication nonadherence based on a composite score threshold (secondary) at the 6-week postpartum follow-up visit. Participants without follow-up BP measurements were excluded from analysis of the BP control outcome. Participants without health care professional-prescribed antihypertensives at delivery were excluded from the analysis of the adherence outcome. Multivariable logistic regression was used to adjust for potential confounders.Of 2,408 participants, 1,684 (864 active, 820 control) were included in the analysis. A greater percentage of participants in the active group achieved BP control (56.7% vs 51.5%; adjusted odds ratio [aOR] 1.22, 95% CI, 1.00-1.48) than in the control group. Postpartum antihypertensive prescription was higher in the active group (81.7% vs 58.4%, P<.001), and nonadherence did not differ significantly between groups (aOR 0.81, 95% CI, 0.64-1.03).Antihypertensive treatment of mild chronic hypertension during pregnancy was associated with better BP control below 140/90 mm Hg in the immediate postpartum period.

View details for DOI 10.1097/AOG.0000000000005715

View details for PubMedID 39265175